NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001289

Registered date:03/08/2008

Peripheral blood mononuclear cell implantation for patients with severe ischemic heart disease

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedSevere ischemic heart disease
Date of first enrollment2008/11/01
Target sample size30
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)CABG+injection of 10^7 autologous peripheral blood mononuclear cells CABG+injection of 10^8 autologous peripheral blood mononuclear cells

Outcome(s)

Primary OutcomeSafety throughout this treatment.
Secondary OutcomeImprovement of regional left ventriculer ejection fraction, gloval left ventriculer ejection fraction, perfusion, ischemic mitral regurgitation, symptom.

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteria
Exclude criteriashock emergency operation malignant neoplasm severe retinopathy severe renal dysfunction(including who receiving chronic hemotherapy) femail with pregnancy others

Related Information

Contact

public contact
Name Tohru Minamino
Address Japan
Telephone
E-mail t_minamino@yahoo.co.jp
Affiliation Graduate School of Medicine,Chiba University Department of Cardiovascular Science and Medicine
scientific contact
Name Issei Komuro
Address 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan Japan
Telephone 043-226-2555
E-mail
Affiliation Graduate School of Medicine,Chiba University Department of Cardiovascular Science and Medicine